Generic Zantac Distribution Halted Worldwide; Contamination Concerns
This article was originally published on Medscape.com
Written by Marcia Frellick | Published September 18, 2019
Distribution of generic versions of the popular heartburn drug ranitidine (Zantac, Novartis) is being halted in markets worldwide by the manufacturer, according to a spokesperson for Novartis, after findings that the medication may have become tainted with a cancer-causing agent.
Dana Kahn […]